Physician profile
Nishant Sethi
NPI 1306070735
$1,335,809.03
in general payments reported to CMS, 2019-2025
33 companies · $269K in 2025
The $269K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161K · 2020: $122K · 2021: $221K · 2022: $126K · 2023: $120K · 2024: $316K · 2025: $269K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $326K · Consulting Fee: $169K · Travel and Lodging: $154K · Food and Beverage: $29K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $27K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $326,318.78 |
| Consulting Fee | $168,937.50 |
| Travel and Lodging | $154,289.10 |
| Food and Beverage | $29,031.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $27,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $723,751.60 | 2021-2025 | Corevalve Evolut R, Resolute Onyx, Onyx Frontier |
| Medtronic Vascular, INC. | $281,618.03 | 2019-2020 | |
| Abbott Laboratories | $231,896.60 | 2019-2025 | Navitor, Xience V, Optis |
| Edwards Lifesciences Corporation | $75,512.13 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Bard Peripheral Vascular, INC. | $13,743.52 | 2024-2025 | Fluency Endovascular Stent Graft, True Flow, Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $4,010.50 | 2019-2025 | Avvigo Guidance System, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $1,131.01 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,009.61 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $739.04 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $712.13 | 2021-2025 | |
| Shockwave Medical, INC | $342.93 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $271.21 | 2022-2025 | |
| Gentuity, LLC | $150.82 | 2025 | Gentuity Hf-Oct Imaging System, Vis-Rx Prime |
| Penumbra, INC. | $129.38 | 2024 | Indigo System |
| Teleflex LLC | $121.88 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $78.23 | 2021-2022 | |
| Inari Medical, INC. | $75.89 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $68.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $61.10 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $53.96 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $44.45 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $40.28 | 2025 | |
| Philips North America LLC | $35.82 | 2024 | (Ck7) Extended Holter |
| Terumo Medical Corporation | $33.20 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.55 | 2025 | |
| Novo Nordisk INC | $29.95 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Acist Medical Systems, INC. | $24.87 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.41 | 2024 | Jardiance |
| Imperative Care, INC | $16.60 | 2024 | Symphony Catheter |
| Bridgebio Pharma, INC. | $15.28 | 2025 | Attruby |
| Braemar Manufacturing, LLC | $14.48 | 2019 | |
| Lantheus Medical Imaging, INC. | $13.14 | 2020 | |
| Cardiovascular Systems INC. | $10.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.